about
Novel strong tissue specific promoter for gene expression in human germ cells.New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome.Combinatorial high-throughput experimental and bioinformatic approach identifies molecular pathways linked with the sensitivity to anticancer target drugsHuman-specific endogenous retroviral insert serves as an enhancer for the schizophrenia-linked gene PRODH.In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state.Molecular functions of human endogenous retroviruses in health and disease.Data aggregation at the level of molecular pathways improves stability of experimental transcriptomic and proteomic data.Early stage of cytomegalovirus infection suppresses host microRNA expression regulation in human fibroblasts.Sense transcripts originated from an internal part of the human retrotransposon LINE-1 5' UTR.Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas.[Experimental analysis of human specific protein coding open reading frame c11orf72].A method of gene expression data transfer from cell lines to cancer patients for machine-learning prediction of drug efficiency.Acquired resistance to tyrosine kinase inhibitors may be linked with the decreased sensitivity to X-ray irradiation.[Receptor tyrosine kinase KIT may regulate expression of genes involved in spontaneous regression of neuroblastoma].Oncobox Bioinformatical Platform for Selecting Potentially Effective Combinations of Target Cancer Drugs Using High-Throughput Gene Expression DataPersonalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinomaPersonalized prescription of imatinib in recurrent granulosa cell tumor of the ovary: case report.
P50
Q33660999-3311E0AA-E933-452F-BCA4-BA9927197235Q36181660-AE1EEAD9-CCFD-4451-860C-DC211D85CAAEQ36413738-4E3C1EED-CD49-4A37-B09A-6B9250289726Q37353019-1437BDE0-207D-49A7-B704-2A164CF6C89DQ37361055-B5411E85-666C-4533-82A5-F86B842F55A3Q38529916-BD8A6F2A-5942-4725-BFA4-38EEC35DBAC8Q38616209-A341E270-77D6-42F4-95B9-4E6282C3C3F5Q38723034-10C56F20-DACC-4A16-99B6-4EF991A68E2BQ39277944-B2BC4F7B-8AA8-4EFF-9798-32D7F352F3CAQ44644664-5A72AAD0-EE83-4CD2-9D19-5D9D8FD61F9DQ44904612-36126361-1A2A-4ED8-83E6-12C77641447FQ47173628-E80C0650-800A-4CF3-975C-2FB86C94150DQ50052905-9C66770B-733A-40DE-8A3F-9AD3D361A50DQ53352264-63E28F7A-B195-4EF5-89D0-1F79DED1B1DFQ57064748-02E97546-68DB-46E6-B1A2-81ECCF8B8011Q58761822-09341189-195F-404A-9679-041FDE82636AQ64883485-C4738D95-B002-4BE7-9B78-51612E132F6B
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maria Suntsova
@en
Maria Suntsova
@nl
Marija Wladimirowna Sunzowa
@de
Мария Владимировна Сунцова
@ru
type
label
Maria Suntsova
@en
Maria Suntsova
@nl
Marija Wladimirowna Sunzowa
@de
Мария Владимировна Сунцова
@ru
altLabel
Marija Sunzowa
@de
Mariya Suntsova
@en
Mariya Vladimirovna Suntsova
@en
prefLabel
Maria Suntsova
@en
Maria Suntsova
@nl
Marija Wladimirowna Sunzowa
@de
Мария Владимировна Сунцова
@ru
P106
P21
P31
P496
0000-0002-0280-4446